Skip to main content
. 2023 Apr 8;14(4):258. doi: 10.1038/s41419-023-05776-2

Fig. 7. Schematic summary shows that PRPF19 promotes liver metastasis in CRC.

Fig. 7

PRPF19 enhanced the stability of MYL9 via K63-linked ubiquitination, and the Src-YAP1 pathway acts as the downstream effector mechanism of the PRPF19/MYL9 axis in CRC metastasis.